Longtime supporter now lead less so-/ Cytosorbents Co. (NASDAQ:CTSO – Free Report) – Stock analysts at HC Wainwright dropped their FY2024 earnings estimates for shares of Cytosorbents in a research note issued on Monday, November 11th. HC Wainwright analyst S. Lee now expects that the medical research company will post earnings of ($0.30) per share for the year, down from their prior forecast of ($0.29). HC Wainwright has a “Neutral” rating and a $1.00 price objective on the stock.
Market Data 
Markets 
AI
